Physician profile
Kyle Michael Sutherland
NPI 1295331791
$2,414.46
in general payments reported to CMS, 2019-2025
24 companies · $781 in 2025
The $781 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.97 · 2022: $543 · 2023: $525 · 2024: $488 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $668.92 | 2022-2025 | |
| Pfizer INC. | $495.91 | 2022-2025 | |
| Novo Nordisk INC | $157.82 | 2022-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $149.54 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $149.08 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $120.87 | 2021-2025 | Mounjaro, Zepbound |
| Phathom Pharmaceuticals, INC. | $100.61 | 2024-2025 | Voquezna |
| Amgen INC. | $98.86 | 2021-2023 | Otezla, Repatha |
| Boston Scientific Corporation | $45.47 | 2021-2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $44.70 | 2023-2024 | Breztri, Airsupra |
| Philips North America LLC | $43.94 | 2021-2024 | (Ak6) Vest Therapy |
| Novartis Pharmaceuticals Corporation | $43.47 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.44 | 2025 | Xifaxan |
| Tactile Systems Technology INC | $39.22 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Bayer Healthcare Pharmaceuticals INC. | $27.42 | 2022-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $27.28 | 2025 | |
| Zimmer Biomet Holdings, INC. | $26.63 | 2024 | Comprehensive Shoulder System |
| Alkermes, INC. | $25.03 | 2023 | Vivitrol |
| Sunovion Pharmaceuticals INC. | $23.31 | 2022 | |
| Xeris Pharmaceuticals, INC. | $21.86 | 2024 | Gvoke Hypopen |
| Ultragenyx Pharmaceutical INC. | $16.83 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.29 | 2024 | Eliquis |
| Bioventus LLC | $16.09 | 2025 | Exogen Ultrasound Bone Healing System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Sutherland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.